Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0W4VH
|
|||
| Former ID |
DIB006523
|
|||
| Drug Name |
Peptide-T
|
|||
| Synonyms |
Peptide T; Peptide-T, Carlbiotech; Peptide-T, Peptech
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Neurodegenerative disorder [ICD-11: 8A20-8A23] | Phase 2 | [1] | |
| Company |
Carlbiotech Ltd; Peptech (UK) Ltd
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C35H55N9O16
|
|||
| Canonical SMILES |
CC(C(C(=O)NC(C(C)O)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CO)NC(=O)C(C)N)O
|
|||
| InChI |
1S/C35H55N9O16/c1-13(36)28(52)40-22(12-45)31(55)41-25(15(3)47)33(57)43-26(16(4)48)34(58)42-24(14(2)46)32(56)39-21(11-23(37)51)29(53)38-20(10-18-6-8-19(50)9-7-18)30(54)44-27(17(5)49)35(59)60/h6-9,13-17,20-22,24-27,45-50H,10-12,36H2,1-5H3,(H2,37,51)(H,38,53)(H,39,56)(H,40,52)(H,41,55)(H,42,58)(H,43,57)(H,44,54)(H,59,60)/t13-,14+,15+,16+,17+,20-,21-,22-,24-,25-,26-,27-/m0/s1
|
|||
| InChIKey |
IWHCAJPPWOMXNW-LYKMMFCUSA-N
|
|||
| CAS Number |
CAS 106362-32-7
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00000392) Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment.. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.